Cleared Traditional

K881867 - NEEDLE EJECTOR

K881867 is an FDA 510(k) clearance for NEEDLE EJECTOR, manufactured by Howard, Hills & Harsh. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 203-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
203d
Days
Class 2
Risk

K881867 is an FDA 510(k) clearance for the NEEDLE EJECTOR. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Howard, Hills & Harsh (Salt Lake City, US). The FDA issued a Cleared decision on November 22, 1988 after a review of 203 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K881867

510(k) Number K881867 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1988
Decision Date November 22, 1988
Days to Decision 203 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d slower than avg
Panel avg: 129d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 755
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K881867.
CONTROL SYRINGE
K884497 · Professional Medical Services · Dec 1988
FRANTZ MEDICAL SHARPS COLLECTOR
K884589 · Franklin Medical USA, Inc. · Dec 1988
RETRACTABLE NEEDLE 3CC SYRINGE
K881454 · Kenmar Medical · Dec 1988
NEEDLE REMOVER
K881866 · Howard, Hills & Harsh · Nov 1988
PISTON SYRINGE WITH NEEDLE
K883033 · Select Sources, Inc. · Oct 1988
INSULIN SYRINGE
K883078 · Select Sources, Inc. · Oct 1988